Intravesical recurrence after bladder-sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome
Urologic Oncology: Seminars and Original Investigations Apr 04, 2018
van de Kamp M, et al. - The incidence of intravesical recurrences after small cell carcinoma of the bladder (SCCB) and their management were determined. SCCB was noted to be a serious potentially lethal disease. A high percentage, even in patients with limited disease (LD)-SCCB, rapidly developed systemic disease. To control the disease, systemic therapy was more important than the type of local treatment. A reasonable alternative to major surgery could be a bladder-sparing approach. Nonetheless, isolated intravesical recurrence occurred even after many years in those surviving long enough. A long-term follow-up was suggested because salvage therapy could be successful in the majority of patients.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries